Interpretation of Pharmacovigilance Disproportionality Analyses-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interpretation of Pharmacovigilance Disproportionality Analyses

Published:2023-05-30 Issue:4 Volume:114 Page:745-746
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Khouri Charles¹²^ORCID,Fusaroli Michele³,Salvo Francesco⁴⁵,Raschi Emanuel³^ORCID

Affiliation:

1. Pharmacovigilance Unit Grenoble Alpes University Hospital Grenoble France

2. Inserm U1300, HP2 Laboratory Univ. Grenoble Alpes Grenoble France

3. Pharmacology Unit, Department of Medical and Surgical Sciences University of Bologna Bologna Italy

4. INSERM, BPH, U1219, Team AHeaD Univ. Bordeaux Bordeaux France

5. Pôle de Santé Publique, Service de Pharmacologie Médicale CHU de Bordeaux Bordeaux France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2951

Reference6 articles.

1. COVID‐19 Vaccination and the Incidence of De Novo or Recurrent Rheumatoid Arthritis: A French and International (VigiBase) Signal Detection Study

2. Case–non-case studies: Principle, methods, bias and interpretation

3. Safety Monitoring of COVID ‐19 Vaccines: Perspective from the European Medicines Agency

4. High prevalence of spin was found in pharmacovigilance studies using disproportionality analyses to detect safety signals: a meta-epidemiological study

5. Misrepresentation and distortion of research in biomedical literature

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration;Drug Safety;2024-05-07

2. The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement;Drug Safety;2024-05-07

3. Peer Review in Pharmacovigilance: Lens on Disproportionality Analysis;Drug Safety;2024-03-18

4. Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment;Vaccines;2024-02-11

5. Editorial: Traditional and innovative approaches for signal detection;Frontiers in Drug Safety and Regulation;2024-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3